"Hemangioblastoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2)
Descriptor ID |
D018325
|
MeSH Number(s) |
C04.557.645.375.380.370
|
Concept/Terms |
Multiple Hemangioblastomas- Multiple Hemangioblastomas
- Hemangioblastoma, Multiple
- Hemangioblastomas, Multiple
- Multiple Hemangioblastoma
|
Below are MeSH descriptors whose meaning is more general than "Hemangioblastoma".
Below are MeSH descriptors whose meaning is more specific than "Hemangioblastoma".
This graph shows the total number of publications written about "Hemangioblastoma" by people in this website by year, and whether "Hemangioblastoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemangioblastoma" by people in Profiles.
-
Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature. Childs Nerv Syst. 2023 05; 39(5):1361-1363.
-
Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer. 2022 02 01; 128(3):435-446.
-
Use of optical coherence tomography angiography in the diagnosis of small retina lesions in Von Hippel-Lindau disease. Eye (Lond). 2020 12; 34(12):2345-2346.
-
Efficacy of Retinal Lesion Screening in Von Hippel-Lindau Patients With Widefield Color Fundus Imaging Versus Widefield FA. Ophthalmic Surg Lasers Imaging Retina. 2019 11 01; 50(11):e260-e265.
-
In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease. J Clin Endocrinol Metab. 2018 04 01; 103(4):1631-1638.
-
CNS hemangioblastomatosis in a patient without von Hippel-Lindau disease. CNS Oncol. 2017 04; 6(2):101-105.
-
Neurological Management of Von Hippel-Lindau Disease. Neurologist. 2016 Sep; 21(5):73-8.
-
Expression of HIF-1 regulated proteins vascular endothelial growth factor, carbonic anhydrase IX and hypoxia inducible gene 2 in hemangioblastomas. Folia Neuropathol. 2014; 52(3):234-42.
-
Posterior fossa surgery in octogenarians: special considerations. Clin Neurol Neurosurg. 2013 Oct; 115(10):2200-3.
-
N-butyl 2-cyanoacrylate (n-BCA) embolization of a cerebellar hemangioblastoma. J Neurointerv Surg. 2011 Dec 01; 3(4):386-9.